---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038649"
form_type: "8-K"
ticker: "DARE"
cik: "0001401914"
company_name: "Dare Bioscience, Inc."
filed_at: "2026-08-17T12:35:37+00:00"
generated_at: "2026-08-17T12:40:38.685308+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Daré Bioscience prices $6.0M registered direct offering at $1.37/share

## Summary
- Offering of 4,379,581 shares (or pre-funded warrants) at $1.37/share; gross proceeds ~$6.0M.
- Concurrent private placement of Series A and B warrants for up to 4,379,581 shares each, exercise price $1.37, subject to stockholder approval.
- Closing expected on or about August 17, 2026; Ladenburg Thalmann acting as exclusive placement agent.
- Proceeds to fund working capital, 503B compounding, consumer health strategies, R&D, and general corporate purposes.

## SEC filing metadata
- accession: 0001493152-26-038649
- form_type: 8-K
- ticker: DARE
- cik: 0001401914
- company_name: Dare Bioscience, Inc.
- filed_at: 2026-08-17T12:35:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401914/000149315226038649/0001493152-26-038649-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401914/000149315226038649/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038649
- JSON: https://secwatch.observer/filing/0001493152-26-038649.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038649.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.